FDA data Registry peer set 5 peers FDA shortage listed

Alternatives to voriconazole

FDA shortage status is active for voriconazole; 5 same-class SPL records are listed below for registry comparison only.

Brand: Vfend

Azole Antifungal Prescription 5 alternatives found

voriconazole class peers while FDA lists an active shortage

voriconazole (Vfend) is on an FDA shortage listing while 5 other Azole Antifungal SPL records remain in this registry peer set (class inventory 6). Labeled indication field for voriconazole: This medicine treats several types of fungal infections.

Top FAERS reaction fields for voriconazole total 11,984 reports across 10 reactions, set beside fluconazole, isavuconazonium, itraconazole. Counts are exposure-weighted submissions, not per-patient risk.

About voriconazole

Voriconazole (Vfend) is an antifungal medicine. It is used to treat serious fungal infections in adults and children 2 years and older.

Used for: This medicine treats several types of fungal infections. It is used for invasive aspergillosis, a lung infection. It also treats candidemia (a blood infection) and other Candida infections in the skin, abdomen, kidney, bladder, and wounds. Voriconazole can also treat esophageal candidiasis (a throat infection) and serious infections caused by Scedosporium and Fusarium fungi.

5 Azole Antifungal peers (wide set)

Compare voriconazole vs fluconazole side-by-side →

voriconazole vs fluconazole & isavuconazonium · FAERS reaction fields

FAERS top-reaction field "Pyrexia" shows the widest count spread between voriconazole and fluconazole, isavuconazonium, itraconazole in this extract (2,710-report gap on that field). Counts are exposure-weighted submissions, not prevalence rates.

Side Effect voriconazole fluconazoleisavuconazoniumitraconazole
Drug Interaction 2,315 2,934 84 1,118
Death 1,460 2,137 310 266
Pyrexia 1,411 4,121 125 568
Pneumonia 1,321 2,851 114 461
Condition Aggravated 1,093 - 106 387
Bronchopulmonary Aspergillosis 1,028 - - -
Febrile Neutropenia 888 2,661 135 362
Aspergillus Infection 873 - 56 -

"-" means no reports for that reaction. Report counts reflect total FAERS submissions, not prevalence rates.

voriconazole shortage vs Azole Antifungal peer index

Shortage status

FDA shortage listing is active for voriconazole (status: To Be Discontinued). Peer rows remain a registry index, not a switch guide.

Frequently Asked Questions

Does FDA list a shortage for voriconazole while peers remain indexed?
Yes - voriconazole matched an active FDA shortage listing (To Be Discontinued) while 5 other Azole Antifungal SPL records remain in this peer index for field comparison only.

Registry note: Shortage listings and peer indexes are for registry orientation only. This information is for educational purposes only and is not a substitute for professional medical advice. Do not stop or change your medication without talking to your doctor or pharmacist.

Full voriconazole profile →

Field note for voriconazole: see also the generic vs brand label guide when reading Vfend SPL strings.